ArticleJournal of imaging informatics in medicine2026
New Machine Learning Method for Medical Image and Microarray Data Analysis for Heart Disease Classification.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microarray technology has become a vital tool in cardiovascular research, enabling the simultaneous analysis of thousands of gene expressions. This capability provides a robust foundation for heart disease classification and biomarker discovery. However, the high dimensionality, noise, and sparsity of microarray data present significant challenges for effective analysis. Gene selection, which aims to identify the most relevant subset of genes, is a crucial preprocessing step for improving classification accuracy, reducing computational complexity, and enhancing biological interpretability. Traditional gene selection methods often fall short in capturing complex, nonlinear interactions among genes, limiting their effectiveness in heart disease classification tasks. In this study, we propose a novel framework that leverages deep neural networks (DNNs) for optimizing gene selection and heart disease classification using microarray data. DNNs, known for their ability to model complex, nonlinear patterns, are integrated with feature selection techniques to address the challenges of high-dimensional data. The proposed method, DeepGeneNet (DGN), combines gene selection and DNN-based classification into a unified framework, ensuring robust performance and meaningful insights into the underlying biological mechanisms. Additionally, the framework incorporates hyperparameter optimization and innovative U-Net segmentation techniques to further enhance computational performance and classification accuracy. These optimizations enable DGN to deliver robust and scalable results, outperforming traditional methods in both predictive accuracy and interpretability. Experimental results demonstrate that the proposed approach significantly improves heart disease classification accuracy compared to other methods. By focusing on the interplay between gene selection and deep learning, this work advances the field of cardiovascular genomics, providing a scalable and interpretable framework for future applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.